SBIR/STTR Research Award

Rapid Estimation of Gene Expression in Tissue Slices

Award identifier ab04a6936531208c1e202144ef394bd4969c43a0828a6398d49741e6ffc0051cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$200,902

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
TIRF Technologies
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Decisions made by surgeons, pathologists, and other physicians during cancer therapy depend largely on how the malignancy is classified, a process limited historically to histological criteria. Recent data suggest that the classification process can be improved significantly when the gene expression profile of the tumor is known. The most complete profiles have been obtained using microarray methods, which have the capabilities of monitoring the expression of tens of thousands of genes simultaneously. These analyses have identified mRNA transcripts that are most important for classifying a variety of tumors. Microarray techniques are not readily applicable to single cells, however. Data produced by analyses of whole tissues include values that reflect gene expression in non-transformed as well as transformed cells. Furthermore, tumors may contain more than one transformed cell type, a phenomenon that confounds this analysis and that may lead to errors in classification. Our desire to circumvent the limitations inherent in microarray analyses of whole tissues led us to seek alternate strategies for obtaining this information. We propose to build an instrument capable of monitoring simultaneously several mRNA transcripts in single cells of frozen sections. Its design makes use of well-known properties of fluorescence spectroscopy and should enable these data to be acquired during surgery. This will permit pathologists and surgeons to better assess the nature of the tumor at the time when decisions must made regarding the extent of the surgical procedure. It will also permit physicians to better tailor subsequent treatments that may involve radiation and chemotherapy, treatments that can have debilitating side effects.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.